Innocan Pharma Corporation

About Innocan Pharma Corporation

Innocan Pharma focuses on innovative non-opioid chronic pain management and wellness solutions, aiming to improve human and animal health through pharmaceutical and CBD-based wellness products.

Products & Services

Pharmaceuticals:Development of non-opioid solutions for chronic pain management.

Human Health:Products and solutions targeting health and pain management for humans.

Animal Health:Innovative health solutions for animals, focusing on pain management.

CBD Wellness:Wellness products infused with CBD for health and relaxation.

Pre-Clinical Studies:Research and studies to support the development of new health solutions.

Regulatory Pipeline:Management of regulatory processes for product approvals.

Specialties

Non-opioid chronic pain management CBD wellness Human and animal health solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 214839 MR: - FA: $214,839 FAN: 214839	D: 2025-04-15 FD: 2025-04-15	-
2	RT: Debt T: - FT: Debt	A: 1000000 MR: - FA: US $1,000,000 FAN: 1000000	D: 2025-03-07 FD: 2025-03-07	1 investors
3	RT: Debenture T: - FT: Debenture	A: 1000000 MR: - FA: US $1,000,000 FAN: 1000000	D: 2025-02-27 FD: 2025-02-27	1 investors
4	RT: Private Placement T: - FT: Private Placement	A: 635445 MR: - FA: C$635,444.60 FAN: 635445	D: 2024-12-31 FD: 2024-12-31	-
5	RT: Private Placement T: - FT: Private Placement	A: 700000 MR: - FA: C$700,000 FAN: 700000	D: 2024-12-19 FD: 2024-12-19	-
6	RT: Private Placement T: - FT: Private Placement	A: 807131 MR: - FA: C$1,105,659.50 FAN: 807131	D: 2024-08-29 FD: 2024-08-29	-
7	RT: Private Placement T: - FT: Private Placement	A: 1988210 MR: - FA: C$1,988,210 FAN: 1988210	D: 2024-03-14 FD: 2024-03-14	-
8	RT: Private Placement T: - FT: Private Placement	A: 426060 MR: - FA: $426,060 FAN: 426060	D: 2023-10-12 FD: 2023-10-12	1 investors
9	RT: Private Placement T: - FT: Private Placement	A: 3000000 MR: - FA: up to $3,000,000 FAN: 3000000	D: 2023-09-21 FD: 2023-09-21	-
10	RT: Private Placement T: - FT: Private Placement	A: 1934239 MR: - FA: C$1,934,239 FAN: 1934239	D: 2023-08-04 FD: 2023-08-04	-
11	RT: Private Placement T: - FT: Private Placement	A: 3960600 MR: - FA: C$3,960,600 FAN: 3960600	D: 2023-07-25 FD: 2023-07-25	-

Private Placement Latest

2025-04-15

$215K

Debt 2025-03-07

$1.0M

Debenture 2025-02-27

$1.0M

View 10 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

IRIS BINCOVICH

Chief Executive Officer

R

RONI KAMHI

Chief Operating Officer

N

NELSON HALPERN

FCPA, FCA, TEP CFO

E

EYAL KALO

Vice President, R&D

E

EYAL FLOM

General Counsel

C

Chezy Barenholz

Scientific Advisor

View 9 more team members with Pro

Unlock Full Team Directory

Recent News